When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
Since the post-deal lows of $114, Allergan (AGN) is up over 60%. The deal hasn't boosted AbbVie (ABBV) to similar levels, but now isn't the time to cash out of Allergan and shift into the very cheap AbbVie. My investment thesis remains bullish on holding Allergan into the deal close and staying around for AbbVie shares.
The official deal involves AbbVie offering an original price of $188.24 per share to acquire Allergan that had dipped to $115. The offer price to Allergan shareholders is $120.30